Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations.

Schroeder RD, Angelo LS, Kurzrock R.

Oncotarget. 2014 Jan 15;5(1):67-77. Review.

2.

Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.

Kley N, Whaley J, Seizinger BR.

Glia. 1995 Nov;15(3):297-307. Review.

PMID:
8586465
3.

Role of the neurofibromatosis type 2 gene in the development of tumors of the nervous system.

Ruttledge MH, Rouleau GA.

Neurosurg Focus. 2005 Nov 15;19(5):E6. Review.

PMID:
16398470
4.

Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors.

Louis DN, Ramesh V, Gusella JF.

Brain Pathol. 1995 Apr;5(2):163-72. Review.

PMID:
7670657
5.

Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.

Yang C, Asthagiri AR, Iyer RR, Lu J, Xu DS, Ksendzovsky A, Brady RO, Zhuang Z, Lonser RR.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4980-5. doi: 10.1073/pnas.1102198108. Epub 2011 Mar 7.

6.

Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.

Stemmer-Rachamimov AO, Ino Y, Lim ZY, Jacoby LB, MacCollin M, Gusella JF, Ramesh V, Louis DN.

J Neuropathol Exp Neurol. 1998 Dec;57(12):1164-7.

PMID:
9862639
7.

[Molecular biological analysis of neurofibromatosis type 2 gene].

Ichimura K, Yuasa Y.

Nihon Rinsho. 1993 Sep;51(9):2462-6. Review. Japanese.

PMID:
8411729
8.

Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.

Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER.

Hum Mol Genet. 1994 Feb;3(2):347-50.

PMID:
8004107
9.

[Neurofibromatosis type 2 (NF2)].

Araki N, Takeshima H, Saya H.

Gan To Kagaku Ryoho. 1997 Sep;24(11):1427-31. Review. Japanese.

PMID:
9309136
10.

Functional analysis of neurofibromatosis 2 (NF2) missense mutations.

Gutmann DH, Hirbe AC, Haipek CA.

Hum Mol Genet. 2001 Jul 1;10(14):1519-29.

PMID:
11448944
11.

NF2: the wizardry of merlin.

Xiao GH, Chernoff J, Testa JR.

Genes Chromosomes Cancer. 2003 Dec;38(4):389-99. Review.

PMID:
14566860
13.

Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).

Halum SL, Erbe CB, Friedland DR, Wackym PA.

Otolaryngol Head Neck Surg. 2003 Mar;128(3):364-71.

PMID:
12646839
14.
15.

Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.

Beltrami S, Kim R, Gordon J.

Anticancer Res. 2013 Jan;33(1):1-11. Review.

16.

Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.

Irving RM, Harada T, Moffat DA, Hardy DG, Whittaker JL, Xuereb JH, Maher ER.

Am J Otol. 1997 Nov;18(6):754-60.

PMID:
9391673
17.

Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.

Wolff RK, Frazer KA, Jackler RK, Lanser MJ, Pitts LH, Cox DR.

Am J Hum Genet. 1992 Sep;51(3):478-85.

18.

Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.

Kluwe L, Bayer S, Baser ME, Hazim W, Haase W, F√ľnsterer C, Mautner VF.

Hum Genet. 1996 Nov;98(5):534-8. Erratum in: Hum Genet 1997 Feb;99(2):292.

PMID:
8882871
19.

Neurofibromatosis type 2 appears to be a genetically homogeneous disease.

Narod SA, Parry DM, Parboosingh J, Lenoir GM, Ruttledge M, Fischer G, Eldridge R, Martuza RL, Frontali M, Haines J, et al.

Am J Hum Genet. 1992 Sep;51(3):486-96.

20.

Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.

Kluwe L, Friedrich RE, Hagel C, Lindenau M, Mautner VF.

J Invest Dermatol. 2000 May;114(5):1017-21.

Supplemental Content

Support Center